NOVO BANCO, S.A. financials
NOVO BANCO, S.A.
Country: PT Reporting currency: EUR Latest annual report: 2022-12-31
LEI:
5493009W2E2YDCXY6S81 Financial statements
(EUR, as reported — unscaled; 101 line items across 2 annual periods)
| Line item | 2022 | 2021 |
|---|---|---|
| Income statement | ||
| Employee benefits expense | €233.7M | €233.3M |
| Depreciation & amortisation | €52.5M | €34.0M |
| Profit before tax | €532.9M | €172.1M |
| Income tax expense | -€53.3M | -€15.2M |
| Profit for the year | €585.9M | €192.2M |
| — attributable to owners | €560.8M | €184.5M |
| — attributable to NCI | €25.1M | €7.7M |
| Total comprehensive income | €396.9M | -€29.9M |
| Per share | ||
| Basic EPS | €0.06 | €0.02 |
| Diluted EPS | €0.06 | €0.02 |
| Free cash flow / share | €0.02 | €0.22 |
| Cash flow statement | ||
| Net cash from operating activities | €314.2M | €2.18B |
| Net cash from investing activities | €298.6M | -€733.0K |
| Purchase of PP&E (capex) | €137.5M | €82.0M |
| Purchase of intangibles | €25.3M | €25.7M |
| Net cash from financing activities | €91.7M | €992.2M |
| Balance sheet | ||
| Total assets | €46.00B | €44.62B |
| Intangible assets & goodwill | €69.8M | €68.0M |
| Cash & equivalents | €6.60B | €5.87B |
| Total equity | €3.51B | €3.15B |
| — attributable to owners | €560.8M | €184.5M |
| Non-controlling interests | €18.3M | €31.0M |
| Deferred tax liabilities | €845.0K | €3.0M |
| Derived metrics | ||
| Free cash flow | €176.7M | €2.10B |
| Return on equity | 16.7% | 6.1% |
| Cash conversion ratio | 0.54× | 11.36× |
| Capex coverage | 2.28× | 26.63× |
| Other reported items | ||
| Accumulated Other Comprehensive Income | -€1.23B | -€1.05B |
| Basic Earnings Loss Per Share From Continuing Operations | €0.06 | €0.02 |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €6.31B | €5.61B |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | -€1.6M | €365.0K |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | €4.0K |
| Comprehensive Income Attributable To Noncontrolling Interests | €25.1M | €7.7M |
| Comprehensive Income Attributable To Owners of Parent | €371.8M | -€37.6M |
| Current Tax Assets | €32.6M | €35.7M |
| Current Tax Expense Income | €10.0M | €12.7M |
| Current Tax Liabilities | €7.6M | €12.3M |
| Deferred Tax Assets | €923.4M | €744.2M |
| Deferred Tax Expense Income | -€63.3M | -€27.9M |
| Deposits From Banks | €9.71B | €10.75B |
| Deposits From Customers | €29.28B | €27.58B |
| Derivative Financial Assets Held For Hedging | €562.8M | €19.6M |
| Derivative Financial Liabilities Held For Hedging | €119.6M | €44.5M |
| Derivative Financial Liabilities Held For Trading | €99.4M | €306.1M |
| Diluted Earnings Loss Per Share From Continuing Operations | €0.06 | €0.02 |
| Dividends Received Classified As Investing Activities | €5.0M | €11.1M |
| Equity and Liabilities | €46.00B | €44.62B |
| Fee and Commission Expense | €47.2M | €47.4M |
| Fee and Commission Income | €337.3M | €325.5M |
| Financial Assets At Fair Value Through Profit Or Loss | €13.0K | €0 |
| Financial Assets At Fair Value Through Profit Or Loss Classified As Held For Trading | €171.8M | €377.7M |
| Financial Assets Measured At Fair Value Through Other Comprehensive Income | €2.33B | €7.22B |
| Gains Losses On Exchange Differences On Translation Net of Tax | -€892.0K | €95.0K |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | €6.8M | €10.8M |
| Impairment Loss Impairment Gain and Reversal of Impairment Loss Determined In Accordance With IFRS9 | €101.9M | €198.9M |
| Income Taxes Paid Refund Classified As Operating Activities | €44.8M | €35.6M |
| Increase Decrease In Cash and Cash Equivalents | €704.6M | €3.17B |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Transfers and Other Changes Equity | -€34.7M | -€7.2M |
| Interest Expense | €209.2M | €167.1M |
| Interest Paid Classified As Operating Activities | €211.9M | €160.7M |
| Interest Received Classified As Operating Activities | €862.7M | €678.7M |
| Interest Revenue Expense | €625.5M | €573.4M |
| Investment Property | €499.6M | €625.2M |
| Investments In Associates Accounted For Using Equity Method | €119.7M | €94.6M |
| Issue of Equity | €0 | €0 |
| Issued Capital | €6.30B | €6.05B |
| Liabilities | €42.48B | €41.47B |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €15.5M | €968.0K |
| Loans and Advances To Banks | €43.5M | €50.5M |
| Loans and Advances To Customers | €24.55B | €23.65B |
| Miscellaneous Other Operating Expense | €118.4M | €181.6M |
| Miscellaneous Other Operating Income | €214.0M | €163.9M |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €59.6M | €9.4M |
| Other Assets | €1.62B | €2.44B |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | -€100.4M | €0 |
| Other Comprehensive Income Net of Tax Financial Assets Measured At Fair Value Through Other Comprehensive Income | -€204.7M | -€139.3M |
| Other Comprehensive Income Net of Tax Gains Losses From Investments In Equity Instruments | €14.8M | -€7.0M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €101.7M | -€75.6M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€306.0M | -€139.2M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €116.9M | -€82.9M |
| Other Financial Liabilities | €375.3M | €374.6M |
| Other Liabilities | €839.9M | €443.4M |
| Other Provisions | €413.4M | €442.8M |
| Payments To Suppliers For Goods and Services and To and On Behalf of Employees | €362.2M | €330.9M |
| Proceeds From Issue of Bonds Notes and Debentures | €106.0M | €575.0M |
| Proceeds From Sales of Intangible Assets Classified As Investing Activities | €4.0K | €0 |
| Proceeds From Sales of Investment Property | €367.2M | €100.0M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €107.3M | €424.0K |
| Profit Loss From Continuing Operations | €586.2M | €187.3M |
| Profit Loss From Discontinued Operations | -€270.0K | €4.9M |
| Purchase of Investment Property | €16.5M | €5.0M |
| Receipts From Royalties Fees Commissions and Other Revenue | €337.3M | €325.5M |
| Repayments of Bonds Notes and Debentures | €14.3M | €11.8M |
| Repurchase Agreements and Cash Collateral On Securities Lent | €2.15B | €1.53B |
| Retained Earnings Excluding Profit Loss For Reporting Period | -€8.58B | -€8.58B |
| Revenue From Dividends | €5.0M | €11.1M |
| Revenue From Interest | €834.7M | €740.5M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Not Be Reclassified To Profit Or Loss Net of Tax | €332.0K | -€252.0K |
| Share of Profit Loss of Associates Accounted For Using Equity Method | €8.4M | €3.8M |
| Trading Income Expense | €149.2M | €50.9M |
Methodology
Every line item above is a fact tagged in NOVO BANCO, S.A.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.